vs

Side-by-side financial comparison of NEPHROS INC (NEPH) and VerifyMe, Inc. (VRME). Click either name above to swap in a different company.

VerifyMe, Inc. is the larger business by last-quarter revenue ($5.0M vs $4.7M, roughly 1.1× NEPHROS INC). NEPHROS INC runs the higher net margin — 1.3% vs -66.7%, a 68.0% gap on every dollar of revenue. On growth, NEPHROS INC posted the faster year-over-year revenue change (22.2% vs -7.4%). Over the past eight quarters, NEPHROS INC's revenue compounded faster (15.9% CAGR vs -5.2%).

Nephros Inc is a medical technology company that develops and commercializes high-performance water purification systems, infection control products, and renal care solutions. Its offerings are primarily used by hospitals, dialysis clinics, and long-term care facilities across North America to reduce waterborne pathogen risks and improve patient outcomes.

VerifyMe, Inc. is a technology provider specializing in identity verification, anti-counterfeiting, and brand protection solutions. Its offerings include secure authentication tools, supply chain traceability systems, and customer engagement platforms, serving consumer goods, pharmaceutical, and retail sectors across North America and select global markets.

NEPH vs VRME — Head-to-Head

Bigger by revenue
VRME
VRME
1.1× larger
VRME
$5.0M
$4.7M
NEPH
Growing faster (revenue YoY)
NEPH
NEPH
+29.6% gap
NEPH
22.2%
-7.4%
VRME
Higher net margin
NEPH
NEPH
68.0% more per $
NEPH
1.3%
-66.7%
VRME
Faster 2-yr revenue CAGR
NEPH
NEPH
Annualised
NEPH
15.9%
-5.2%
VRME

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
NEPH
NEPH
VRME
VRME
Revenue
$4.7M
$5.0M
Net Profit
$62.0K
$-3.4M
Gross Margin
58.4%
41.2%
Operating Margin
0.4%
-68.2%
Net Margin
1.3%
-66.7%
Revenue YoY
22.2%
-7.4%
Net Profit YoY
-82.2%
-38.4%
EPS (diluted)
$0.01
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NEPH
NEPH
VRME
VRME
Q4 25
$4.7M
Q3 25
$4.8M
$5.0M
Q2 25
$4.4M
$4.5M
Q1 25
$4.9M
$4.5M
Q4 24
$3.9M
Q3 24
$3.5M
$5.4M
Q2 24
$3.3M
$5.4M
Q1 24
$3.5M
$5.8M
Net Profit
NEPH
NEPH
VRME
VRME
Q4 25
$62.0K
Q3 25
$337.0K
$-3.4M
Q2 25
$237.0K
$-291.0K
Q1 25
$558.0K
$-571.0K
Q4 24
$349.0K
Q3 24
$183.0K
$-2.4M
Q2 24
$-289.0K
$-346.0K
Q1 24
$-169.0K
$-553.0K
Gross Margin
NEPH
NEPH
VRME
VRME
Q4 25
58.4%
Q3 25
61.2%
41.2%
Q2 25
63.2%
35.2%
Q1 25
64.7%
33.4%
Q4 24
64.0%
Q3 24
61.1%
34.9%
Q2 24
58.8%
39.1%
Q1 24
62.1%
39.2%
Operating Margin
NEPH
NEPH
VRME
VRME
Q4 25
0.4%
Q3 25
6.6%
-68.2%
Q2 25
5.6%
-7.1%
Q1 25
11.6%
-13.3%
Q4 24
8.2%
Q3 24
5.9%
-52.8%
Q2 24
-9.7%
-10.0%
Q1 24
-5.7%
-11.2%
Net Margin
NEPH
NEPH
VRME
VRME
Q4 25
1.3%
Q3 25
7.1%
-66.7%
Q2 25
5.4%
-6.4%
Q1 25
11.4%
-12.8%
Q4 24
9.0%
Q3 24
5.2%
-44.6%
Q2 24
-8.9%
-6.5%
Q1 24
-4.8%
-9.6%
EPS (diluted)
NEPH
NEPH
VRME
VRME
Q4 25
$0.01
Q3 25
$0.03
$-0.26
Q2 25
$0.02
$-0.02
Q1 25
$0.05
$-0.05
Q4 24
$0.04
Q3 24
$0.02
$-0.23
Q2 24
$-0.03
$-0.03
Q1 24
$-0.02
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NEPH
NEPH
VRME
VRME
Cash + ST InvestmentsLiquidity on hand
$5.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$10.2M
$11.1M
Total Assets
$13.6M
$13.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NEPH
NEPH
VRME
VRME
Q4 25
$5.4M
Q3 25
$5.2M
Q2 25
$5.1M
Q1 25
$4.1M
Q4 24
$3.8M
Q3 24
$2.5M
$2.6M
Q2 24
$3.1M
$2.9M
Q1 24
$3.6M
$2.8M
Total Debt
NEPH
NEPH
VRME
VRME
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$500.0K
Q2 24
$600.0K
Q1 24
$800.0K
Stockholders' Equity
NEPH
NEPH
VRME
VRME
Q4 25
$10.2M
Q3 25
$10.0M
$11.1M
Q2 25
$9.6M
$14.4M
Q1 25
$9.3M
$14.6M
Q4 24
$8.6M
Q3 24
$8.2M
$10.3M
Q2 24
$7.9M
$12.3M
Q1 24
$8.2M
$12.4M
Total Assets
NEPH
NEPH
VRME
VRME
Q4 25
$13.6M
Q3 25
$13.2M
$13.3M
Q2 25
$12.2M
$17.2M
Q1 25
$11.8M
$17.1M
Q4 24
$11.2M
Q3 24
$10.4M
$14.8M
Q2 24
$11.1M
$17.5M
Q1 24
$11.4M
$17.9M
Debt / Equity
NEPH
NEPH
VRME
VRME
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.05×
Q2 24
0.05×
Q1 24
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NEPH
NEPH
VRME
VRME
Operating Cash FlowLast quarter
$230.0K
$243.0K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.71×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NEPH
NEPH
VRME
VRME
Q4 25
$230.0K
Q3 25
$99.0K
$243.0K
Q2 25
$994.0K
$710.0K
Q1 25
$322.0K
$-404.0K
Q4 24
$1.3M
Q3 24
$-623.0K
$-10.0K
Q2 24
$-501.0K
$372.0K
Q1 24
$-672.0K
$-60.0K
Free Cash Flow
NEPH
NEPH
VRME
VRME
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$-12.0K
Q2 24
$369.0K
Q1 24
$-62.0K
FCF Margin
NEPH
NEPH
VRME
VRME
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-0.2%
Q2 24
6.9%
Q1 24
-1.1%
Capex Intensity
NEPH
NEPH
VRME
VRME
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
0.0%
Q2 24
0.1%
Q1 24
0.0%
Cash Conversion
NEPH
NEPH
VRME
VRME
Q4 25
3.71×
Q3 25
0.29×
Q2 25
4.19×
Q1 25
0.58×
Q4 24
3.74×
Q3 24
-3.40×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NEPH
NEPH

Products$4.6M98%
Other$108.0K2%

VRME
VRME

Proactive Services$4.2M83%
Other$869.0K17%

Related Comparisons